97 related articles for article (PubMed ID: 10095425)
1. [Genetic instability in osteoblastic tumors of the skeletal system].
Roessner A; Radig K; Schneider-Stock R; Mittler U; Neumann HW
Verh Dtsch Ges Pathol; 1998; 82():133-43. PubMed ID: 10095425
[TBL] [Abstract][Full Text] [Related]
2. Genetic instability in osteoblastic tumors of the skeletal system.
Radig K; Schneider-Stock R; Mittler U; Neumann HW; Roessner A
Pathol Res Pract; 1998; 194(10):669-77. PubMed ID: 9820862
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.
Kawaguchi K; Oda Y; Sakamoto A; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2002 Aug; 15(8):878-88. PubMed ID: 12181274
[TBL] [Abstract][Full Text] [Related]
4. [Alterations of MDM2 and p53 genes in bone tumors].
Zhou X; Gao L; Zhe X
Zhonghua Bing Li Xue Za Zhi; 1997 Oct; 26(5):270-2. PubMed ID: 10374333
[TBL] [Abstract][Full Text] [Related]
5. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
[TBL] [Abstract][Full Text] [Related]
6. Alterations of the p53, Rb and MDM2 genes in osteosarcoma.
Miller CW; Aslo A; Won A; Tan M; Lampkin B; Koeffler HP
J Cancer Res Clin Oncol; 1996; 122(9):559-65. PubMed ID: 8781571
[TBL] [Abstract][Full Text] [Related]
7. Status of the p53, Rb and MDM2 genes in canine osteosarcoma.
Mendoza S; Konishi T; Dernell WS; Withrow SJ; Miller CW
Anticancer Res; 1998; 18(6A):4449-53. PubMed ID: 9891508
[TBL] [Abstract][Full Text] [Related]
8. Osteosarcoma in blood relatives.
Longhi A; Benassi MS; Molendini L; Macchiagodena M; Picci P; Bacci G
Oncol Rep; 2001; 8(1):131-6. PubMed ID: 11115584
[TBL] [Abstract][Full Text] [Related]
9. Multiple genetic alterations in hamster pancreatic ductal adenocarcinomas.
Chang KW; Laconi S; Mangold KA; Hubchak S; Scarpelli DG
Cancer Res; 1995 Jun; 55(12):2560-8. PubMed ID: 7780969
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
[TBL] [Abstract][Full Text] [Related]
11. p53 mutation and absence of mdm2 amplification and Ki-ras mutation in 4-hydroxyamino quinoline 1-oxide induced transplantable osteosarcomas in rats.
Kido A; Tsujiuchi T; Tsutsumi M; Takahama M; Okajima E; Kobitsu K; Miyauchi Y; Mii Y; Tamai S; Konishi Y
Cancer Lett; 1997 Jan; 112(1):5-10. PubMed ID: 9029163
[TBL] [Abstract][Full Text] [Related]
12. Alterations of retinoblastoma susceptible gene accompanied by c-myc amplification in human bone and soft tissue tumors.
Ozaki T; Ikeda S; Kawai A; Inoue H; Oda T
Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):235-42. PubMed ID: 8513277
[TBL] [Abstract][Full Text] [Related]
13. p53 and MDM2 alterations in osteosarcomas: correlation with clinicopathologic features and proliferative rate.
Lonardo F; Ueda T; Huvos AG; Healey J; Ladanyi M
Cancer; 1997 Apr; 79(8):1541-7. PubMed ID: 9118036
[TBL] [Abstract][Full Text] [Related]
14. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
Nielsen GP; Burns KL; Rosenberg AE; Louis DN
Am J Pathol; 1998 Jul; 153(1):159-63. PubMed ID: 9665476
[TBL] [Abstract][Full Text] [Related]
15. p53 and ras mutations in Ewing's sarcoma.
Radig K; Schneider-Stock R; Röse I; Mittler U; Oda Y; Roessner A
Pathol Res Pract; 1998; 194(3):157-62. PubMed ID: 9587933
[TBL] [Abstract][Full Text] [Related]
16. [TP53 gene aberrations in chondromatous neoplasms: correlation with immunohistochemical p53 accumulation and MDM2 expression].
Blasenbreu S; Baretton GB; Bender C; Haas CJ; Diebold J; Löhrs U
Verh Dtsch Ges Pathol; 1998; 82():284-9. PubMed ID: 10095448
[TBL] [Abstract][Full Text] [Related]
17. Osteogenic tumors of bone.
Green JT; Mills AM
Semin Diagn Pathol; 2014 Jan; 31(1):21-9. PubMed ID: 24680179
[TBL] [Abstract][Full Text] [Related]
18. Classical osteoblastoma, atypical osteoblastoma, and osteosarcoma: a comparative study based on clinical, histological, and biological parameters.
Oliveira CR; Mendonça BB; Camargo OP; Pinto EM; Nascimento SA; Latorre Mdo R; Zerbini MC
Clinics (Sao Paulo); 2007 Apr; 62(2):167-74. PubMed ID: 17505702
[TBL] [Abstract][Full Text] [Related]
19. Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusion.
Saba KH; Cornmark L; Rissler M; Fioretos T; Åström K; Haglund F; Rosenberg AE; Brosjö O; Nord KH
Genes Chromosomes Cancer; 2019 Oct; 58(10):731-736. PubMed ID: 31066955
[TBL] [Abstract][Full Text] [Related]
20. What's new in bone forming tumours of the skeleton?
Franceschini N; Lam SW; Cleton-Jansen AM; Bovée JVMG
Virchows Arch; 2020 Jan; 476(1):147-157. PubMed ID: 31741049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
